USE OF SULPHATED GLYCOLIPIDS AS PROMOTERS OF NEURITIC GROWTH AND MYELINATION AND INHIBITORS OF THE PROLIFERATION OF ASTROGLIA AND MICROGLIA
申请人:Consejo Superior De Investigaciones Científicas
(CSIC)
公开号:EP2871183A1
公开(公告)日:2015-05-13
The invention relates to the use of a compound having formula I, in which R1 is an alkenyl group C5-C25 containing one or more double carbon-carbon bonds, R2 is selected independently from the group consisting of methyl and fluorinated methyl, and R3 and/or R4 is a SO3M group, in which M is selected from the group consisting of hydrogen, alkali metal, ammonium and quaternary amine, the other being hydrogen or acyl, for the production of a drug for the treatment of central nervous system disorders selected from the group consisting of lesions caused by CNS trauma, demyelinating diseases, neuro-inflammatory diseases and mental disorders caused a low level of BDNF. The invention also relates to compounds having formula I, to methods for producing said compounds and to compositions containing same.
本发明涉及一种具有公式I的化合物的使用,其中R1是含有一个或多个双碳-碳键的C5-C25烯基团,R2独立地选自甲基和氟甲基组成的组,R3和/或R4是SO3M基团,其中M选自由氢、碱金属、铵和季铵组成的组,另一个是氢或酰基,用于制备用于治疗中枢神经系统障碍的药物,该障碍选自由中枢神经系统创伤引起的损伤、脱髓鞘疾病、神经炎症疾病和由低水平脑源性神经营养因子(BDNF)引起的精神障碍。本发明还涉及具有公式I的化合物,制备所述化合物的方法以及包含该化合物的组合物。